DICER1 and cancer: Indeed, reduced Dicer expression has been shown to predict poor patient survival in a number of cancer types, including chronic lymphocytic leukemia [42], breast [43], lung [44], ovarian [45], colorectal [46] and bladder [47,48] cancer.